Answers are grounded in this paper and cite their sources.
Cohort study reveals high mortality and persistent endocrine morbidity following adrenal resection in Cushing's syndrome, highlighting the need for long-term multidisciplinary monitoring.
Summary The course after treatment of 42 patients suffering from Cushing's syndrome is reviewed, the follow‐up period being from twelve months to twelve years. In 30 instances the syndrome was due to bilateral adrenal hyperplasia, in five to adrenal carcinoma, in four to unilateral adenoma, and in three to non‐endocrine carcinoma. Treatment was mainly by adrenal resection—total in the hyperplasia group, unilateral for the adenoma patients. During the follow‐up period 16 patients (38%) have died. These include all eight with carcinoma and eight of the 30 suffering from adrenal hyperplasia. Whilst most of the 26 survivors can be regarded subjectively as being in good health, only ten patients have no clinical abnormality. Hypertension has persisted in nine patients and diabetes in two. Eleven patients have presumed pituitary dysfunction: six of these have pituitary tumours, while a further five have pigmentation only at present. Growth has been interrupted in the two children treated. The psychiatric changes, where present, improved slowly after treatment and three deaths in the hyperplasia group were due to suicide within six months of treatment.
No takes yet. Share an insight, caveat, or question.
Taft et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: